The Meridian published a post on Facebook two days ago raising concerns about the quality of cannabis being sold in Mauritius, based on testimonies from consumers describing symptoms that experienced users described as different from anything they had encountered before. The response was immediate. Within hours, a medical professional had publicly confirmed clinical evidence consistent with adulteration. A community member had named a specific controlled pharmaceutical substance. And hundreds of Mauritians had shared experiences that together describe a pattern no single testimony could establish alone. The Meridian then searched the institutional record. What we found goes far beyond social media testimony. It goes to the heart of a public health crisis that Mauritius's institutions have documented in fragments, in court records, in parliamentary statements and in forensic laboratory reports, but have never assembled into a single coherent public warning. Until today.

Mauritius cannabis adulterated symptoms dependency anxiety chest pain clonazepam rivotril synthetic

The testimonies received by The Meridian and documented in the original Facebook post describe a consistent pattern of symptoms that experienced cannabis users report as distinctly different from natural cannabis. The reported symptoms include severe physical dependency, with users describing an inability to eat without first smoking. Acute anxiety and restlessness between uses. Mood instability and persistent low energy. Stomach discomfort. Loss of appetite unless the substance is consumed. Older and experienced cannabis users specifically noting that the effect feels different, more intense and more physically binding than what they knew before.

These symptoms are not consistent with natural cannabis. Natural cannabis, known scientifically as Cannabis sativa, acts on the brain's endocannabinoid receptors as a partial agonist. It does not cause the physical dependency profile described above under normal circumstances. The inability to eat without smoking, the acute anxiety between uses and the physical binding quality that multiple testimonies describe are consistent with one of two adulterant profiles: synthetic cannabinoids, which are full agonists that bind completely and aggressively to the same receptors with up to 100 times the potency of natural THC, or benzodiazepines such as clonazepam, which act on the brain's GABA system and produce physical dependency within weeks of regular use.

One community member, Beelontally Oozeirl, publicly named a specific substance in response to The Meridian's post. The claim was that Rivotril, the brand name for clonazepam, a prescription-only benzodiazepine controlled substance, is being used as an adulterant, with its active ingredient described as making the effect last longer and creating a stickiness that binds the user to the substance. The Meridian presents this as named community testimony, not as laboratory confirmation. Its pharmacological coherence with the reported symptom profile is, however, exact. Clonazepam builds rapid physical dependency. Its withdrawal produces severe anxiety, restlessness, inability to sleep, stomach discomfort and, in serious cases, seizures. Every symptom in the testimony profile matches benzodiazepine dependency and withdrawal.

Dr Sameer Edun Mauritius medical doctor drug test cannabis adulterated positive other chemicals clinical confirmation

The most significant piece of evidence in this article is not a social media testimony. It is the public statement of Dr Sameer Edun, a medical doctor practising in Mauritius, made on the same Facebook thread in response to The Meridian's original post. Dr Edun stated publicly that he confirms the post is valid. He conducted drug tests with many patients claiming to use cannabis only. They were found positive with various other chemical ingredients. He stated that he does not accept the use of addictive substances to enhance any kind of high.

This is a named medical professional making a specific clinical observation based on drug testing of real patients in a clinical setting. It is not speculation. It is not anonymous testimony. It is a named doctor describing findings from his own clinical practice that are directly consistent with the adulteration hypothesis. Patients who believed they were using cannabis only tested positive for other chemical ingredients. The clinical evidence of adulteration in Mauritius has already been documented in a medical setting. Dr Edun's public statement is, to The Meridian's knowledge, the first time a named Mauritian medical professional has publicly confirmed this finding. It will not be the last, because the institutional data documented below makes clear that this crisis has been building for years.

Mauritius adolescents hospitalised drug 652 2021 2025 parliament Avinash Ramtohul NADC synthetic drugs

On 19 May 2026, two days before this article was published, Avinash Ramtohul responded to a parliamentary question addressed to the Minister of Health Anil Bachoo, who was absent. The data he provided to Parliament describes a trend that has been building silently and that the public health warning community has not yet assembled into a coherent narrative.

The parliamentary data does not specify which substances caused those 652 admissions. It says drug-related health problems. The Meridian asks the question that Parliament did not ask: if a significant proportion of those adolescents believed they were consuming cannabis but were actually consuming synthetic cannabinoids or benzodiazepine-adulterated products, those 652 admissions are not a cannabis problem. They are an adulteration problem presenting as a cannabis problem. The NADC is planning a study on synthetic drug prevalence among secondary school students. The Meridian notes that the study is being planned while the admissions are already accelerating. 173 adolescents in 2025 alone. Some of them 15, 16 or 17 years old, according to la1ere.franceinfo.fr, which reported this week that authorities in Mauritius have been alarmed since the beginning of 2026 by the number of young people found incapacitated in the streets as a consequence of synthetic drug consumption.

EUDA European Union Drugs Agency cannabis adulteration synthetic cannabinoids hemp 2026 report

On 21 May 2026, the same day The Meridian publishes this article, the European Union Drugs Agency published a comprehensive report confirming that the adulteration of cannabis with synthetic cannabinoids is a documented, growing and dangerous phenomenon across Europe. The report confirms that since 2020, there has been an increase in reports of herbal material where natural cannabinoids suggestive of low-THC hemp were found alongside synthetic cannabinoids. At least 13 European countries have reported such cases. The adulterated cannabis appears similar in appearance to natural cannabis and can be mis-sold as cannabis to unsuspecting consumers. Synthetic cannabinoids are highly potent substances and adulterated products carry poisoning risks.

The EUDA currently monitors 247 different synthetic cannabinoids, making them the largest group of new psychoactive substances in Europe, representing 25 per cent of all substances monitored. The agency specifically warns about hot pockets, where the synthetic substance is highly concentrated in one part of the plant material because the spraying process is uneven, creating lethal dose concentrations within what appears to be an ordinary amount of material. Forensic Science Ireland found that more than 50 per cent of cannabis edibles tested in 2022 did not contain THC but contained synthetic cannabinoids instead. In some cases, use of these products by young people has led to poisonings requiring hospitalisation. A production site in the Netherlands was dismantled in 2020 where synthetic cannabinoids were mixed with herbal carrier material, packaged and distributed by post, mainly to Germany. The mechanism documented across Europe is identical to the mechanism that the Mauritius Forensic Science Laboratory has documented in Mauritius for years.

Mauritius FSL Forensic Science Laboratory 5F-ADB AB-FUBINACA synthetic cannabinoids seized Dangerous Drugs Act GN 93 2019

The Mauritius Forensic Science Laboratory has not been unaware of this crisis. It has been documenting it in court records and in the schedules of the Dangerous Drugs Act for years. The specific synthetic cannabinoids seized by the FSL and subsequently scheduled under the Dangerous Drugs Act via GN 93 of 2019 include the following compounds, each of which has been found in Mauritius through FSL analysis submitted as evidence in criminal prosecutions.

The Dangerous Drugs Act was amended specifically because FSL chemists were identifying these compounds in seized material and defence lawyers were arguing that the specific new chemical formula was not yet written into Mauritian law. GN 93 of 2019 created a catch-all legal umbrella covering synthetic cannabinoids and their derivatives. The landmark case Police v. Jeeloll established that any chemical analogue identified by the FSL falls under the ban. This legislative history is the institutional record of a crisis that has been building since at least 2015. The FSL has been finding these substances. The courts have been convicting their sellers. The public has not been warned comprehensively about what is being sprayed onto the plant material being sold as cannabis on the streets of Mauritius.

Mauritius synthetic drugs adulterants brodifacoum rat poison pesticides rubber solvent detergent China import courier

ENACT Africa, the pan-African organised crime research initiative funded by the European Union and implemented by the Institute for Security Studies, ranks Mauritius as number one in the synthetic drug trade in the Southern African Development Community region and in the top ten on the continent. Its analysis of the Mauritian synthetic drug market documents the specific local adulterants that are being used to cut and produce synthetic drug products on the island. These are not imported finished products. They are manufactured locally using imported chemical powders and locally available household substances.

The pure synthetic cannabinoid powders, estimated by ENACT Africa to be approximately 95 per cent imported from China via the internet as white or orange powders or dissolved liquids, are dissolved in a solvent and sprayed onto carrier plant material before being sold. The solvents and cutting agents documented by local public health observers including the National Drug Observatory and ENACT Africa include brodifacoum, the active ingredient in commercial rat poison products available in hardware stores and agricultural supply shops across Mauritius. Pesticides and insecticides. Rubber solvents. And household detergents. These are not sophisticated pharmaceutical adulterants. They are toxic household and agricultural chemicals used because local producers lack basic chemistry knowledge and use whatever is available to dissolve and stretch their product.

The brodifacoum connection is particularly alarming. Brodifacoum is an anticoagulant rodenticide that inhibits the liver enzymes responsible for blood clotting. In 2018, the United States Centers for Disease Control and Prevention responded to a mass outbreak in Illinois where hundreds of people were hospitalised with severe internal bleeding and several died after synthetic cannabis laced with brodifacoum was consumed. The poison was deliberately added because it inhibits the liver enzymes that break down drugs, artificially prolonging the high. Brodifacoum is commercially available in Mauritius as a rodenticide product. Its HS trade code is 293220. It is not a controlled substance. It can be purchased without restriction. And it is documented by the NDO and ENACT Africa as a local adulterant in Mauritius's synthetic drug supply.

The Mauritius Customs Port Control Unit, established in January 2024 under a joint UNODC and World Customs Organization programme, confirmed in its 2024 report that its examinations led to the detection of one case of imported synthetic drugs among the cargo it inspected. MRA Customs and ADSU press releases have documented the interception of synthetic cannabinoid powders arriving via courier services from overseas, predominantly from China. The supply chain for the chemicals that are being sprayed onto plant material sold as cannabis in Mauritius runs from Chinese producers, through international courier services, into local production operations that use household chemicals to dissolve, spray and package the product for sale at prices reaching Rs3,000 per gram. At that price point, buyers are not purchasing natural cannabis. They may be purchasing a chemical cocktail whose individual components include substances capable of causing fatal overdose, severe internal bleeding, cardiac arrest and irreversible kidney damage.

Mauritius Indian Ocean drug network Reunion synthetic drugs regional crisis 2026

The crisis is not confined to Mauritius. La1ere.franceinfo.fr, the French public broadcaster covering Réunion and the Indian Ocean region, reported this week on the alarming scale of synthetic drug consumption among young people in Mauritius, with authorities alarmed since the beginning of 2026 by the number of consumers, some as young as 15 to 17 years old, found incapacitated in the streets. The regional broadcaster previously documented that there are networks within the Indian Ocean, notably involving Mauritius, with a known consumption of opiates and synthetic substances. On 4 May 2026, the Agence Régionale de Santé de La Réunion issued a public health alert after people were intoxicated by CBD products sold legally on the island, confirming that even legal plant-based products in the Indian Ocean region are being found to contain contaminants producing intoxication. The synthetic drug crisis is a regional Indian Ocean phenomenon. Mauritius sits at its documented centre.

Mauritius Ministry of Health ADSU FSL NADC call to action cannabis adulteration public health investigation toxicology

The Meridian takes no position on cannabis legalisation or criminalisation. This article is about one thing only: Mauritians are potentially being sold controlled pharmaceutical substances and synthetic chemicals without their knowledge or consent. A named medical doctor has clinical evidence. The EUDA published a comprehensive report on exactly this phenomenon today. The Mauritius FSL has documented the same compounds in Mauritius for years. The parliamentary data shows 173 adolescent hospitalisations in 2025 alone. The institutional silence in the face of this evidence is itself a public health failure. The Meridian names it today so that the institutions responsible cannot claim they did not know.